Future of Chronic Kidney Disease Diagnostics: Market Insights & Projections
According to FutureWise analysis the market for chronic kidney disease diagnostics in 2023 was US$ 0.85 billion, and is expected to reach US$ 1.44 billion by 2031 at a CAGR of 6.7%.
Chronic kidney disease symptoms like blood in urine, swollen joints, foamy urine, etc are seldom noticed by patients resulting in progressive loss of kidney functions and ultimately renal failure. Delayed diagnosis, lack of sufficient epidemiological data, the significant cost involved in end-stage renal diseases as well as mild kidney diseases have resulted in a substantial need for chronic kidney disease diagnostics. Apart from physical examination by healthcare professionals, certain diagnostics like biopsy or procedures like blood and urine test provide vital stats and early signs about patients neurological, blood vessels and organ conditions. Based on such diagnostic results healthcare professionals can effectively control the kidney symptoms and avoid the progression of chronic kidney disease in their patients.
Factors boosting the chronic kidney disease diagnostics market:
- Rising prevalence of kidney diseases
- Increase in diabetic patients’ population
- Investments into R D for kidney diseases diagnostic techniques
- The ever-emerging healthcare sector
- Extensive use of processed food containing excess potassium and
- The technological advancements in the healthcare diagnostics sector
Besides increased susceptibility of the ageing population due to degrading immune system, diabetics, cardiovascular issues are expected to fuel the growth of the global chronic kidney diseases diagnostics market during the forecast period.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Chronic-Kidney-Disease/137
Chronic Kidney Disease Diagnostics Market Segmentation:
By Product Type
- By Diagnosis
- Blood Tests
- Urine Tests
- Imaging Tests
- Others
- By Treatment
- Drug Class
- ACE Inhibitors
- Angiotensin-II Receptor Blockers
- Diuretics
- Other
- Dialysis
- Other
- Drug Class
By End-User
- Hospitals
- Clinics
- Diagnostic labs
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Competitive Landscape in the Chronic Kidney Disease Diagnostics Market:
- Abbott Laboratories
- AbbVie Inc.
- Amgen Inc.
- Beckman Coulter
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline Plc
- Pfizer Inc
- Siemens Healthineers
- Sysmex Corporation
- Teva Pharmaceutical Industries Ltd
Buy now the latest version of this report:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=137&license=single
**Objectives of this Study: **
- To provide a comprehensive analysis of the Chronic Kidney Disease Diagnostics Market By Product Type, By End-User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian